The U.S. Food and Drug Administration (FDA) said on Friday that it had approved ...
The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann
The drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to be approved, the FDA said in a statement. The combination therapy has been approved to treat hormone receptor positive, HER2-negative breast cancer with mutations of the PIK3CA gene and was fast-tracked under a type of FDA’s pilot program.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
FDA approves Novartis' $2.1 million gene therapy — making it the world's most expensive drugThe therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every 11,000 live births.
और पढो »
“Best if used by.FDA supports manufacturers’ use of the phrase “Best If Used By” to cut down on date confusion
और पढो »
Is Tahini safe? More brands recalled over Salmonella outbreak linkThe FDA are advising people not to eat Karawan, El-Karawan, or SoCo labeled tahini products.
और पढो »
Gene therapy gets FDA approval -- and a $2 million price tagThe FDA approved a treatment for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2. The price tag? $2.125 million for a one-time treatment.
और पढो »
A new drug costs $2.1 million for children with a muscle-wasting diseaseA new drug for treating a rare disease in infants and toddlers is priced at $425,000 per year over five years and is poised to become the nation's most expensive drug.
और पढो »
The FDA approves a gene therapy that is the most expensive drug in the worldThe gene therapy Zolgensma, priced at $2.1 million, treats infants with spinal muscular atrophy.
और पढो »
At $2 Million, New Novartis Drug Is Priciest EverNovartis said it plans to price its recently approved gene therapy at $2.125 million, making it the world’s most expensive medicine.
और पढो »
Buyer beware: So-called sexual enhancement pills sold online can be dangerous for menThe FDA is warning consumers to stay away from dietary supplements claiming to promote sexual enhancement, weight loss or bodybuilding because they may contain hidden ingredients.
और पढो »
The FDA just approved a new treatment for a devastating disease. The price tag is more than $2 million.The treatment, called Zolgensma, should work longer than the typical drug, but also has a much higher price tag.
और पढो »